Arthrospira platensis has been used as a food source for centuries, but serious clinical research into spirulina as a therapeutic supplement only gained momentum in the 1990s and 2000s. Today it has one of the larger evidence bases of any food-based supplement, with multiple meta-analyses across several distinct health endpoints.
Below are seven benefits supported by human clinical data, ranked roughly by strength of evidence.
1. Reduction in LDL Cholesterol and Triglycerides
Spirulina’s most consistent documented effect is on blood lipid profiles. Multiple randomized controlled trials and several meta-analyses confirm that spirulina supplementation reduces total cholesterol, LDL (“bad”) cholesterol, and triglycerides — while modestly increasing HDL (“good”) cholesterol.
A widely cited open study by Torres-Duran et al. examined spirulina supplementation at 4.5 g/day for 6 weeks in healthy Mexican adults. Total cholesterol fell by approximately 10%, LDL by roughly 15%, and triglycerides decreased meaningfully compared to baseline (Torres-Duran et al., 2007).
A subsequent meta-analysis of 7 randomized trials confirmed these directional findings across populations, with spirulina showing statistically significant reductions in LDL and triglycerides (Mazokopakis et al., 2014). The effect is attributed primarily to phycocyanin’s inhibition of lipid peroxidation and its enhancement of antioxidant enzyme activity in the liver — the primary organ for cholesterol synthesis and clearance.
Evidence quality: High. Multiple RCTs and meta-analyses. Effect is consistent across studies and populations.
2. Blood Sugar and HbA1c Reduction
Spirulina has received meaningful research attention for its effects on glucose metabolism, particularly in people with type 2 diabetes or metabolic syndrome.
A randomized study by Lee et al. in Korean adults with type 2 diabetes found that spirulina at 8 grams per day for 12 weeks produced significant reductions in fasting blood glucose and HbA1c compared to placebo (Lee et al., 2008). The study also noted improvements in blood lipid parameters.
Research suggests spirulina may improve blood sugar through multiple mechanisms: reducing oxidative stress in pancreatic beta cells, improving peripheral insulin sensitivity, and slowing the activity of enzymes involved in carbohydrate digestion.
A more recent meta-analysis found that spirulina supplementation produced significant reductions in fasting blood glucose, with stronger effects at higher doses and longer study durations. Effects on HbA1c were more variable across studies, suggesting that spirulina’s blood sugar benefits may be more pronounced for acute glycemic control than for long-term average glucose (Deng and Chow, 2010).
Evidence quality: Moderate to high. Several RCTs showing consistent direction. Most studies are relatively short-term (12 weeks or less).
3. Blood Pressure Reduction
High blood pressure is a major cardiovascular risk factor, and spirulina has been investigated as a nutritional adjunct for hypertensive individuals.
A randomized, double-blind study by Miczke et al. in overweight, hypertensive Caucasian adults found that spirulina at 2 g/day for 3 months produced significant reductions in systolic blood pressure compared to placebo. The effect was most pronounced in participants with the highest baseline blood pressure (Miczke et al., 2016).
The proposed mechanism involves spirulina’s ability to increase nitric oxide (NO) bioavailability in vascular endothelium. Nitric oxide is the primary signaling molecule for blood vessel relaxation; reduced NO production is a key driver of hypertension.
Evidence quality: Moderate. Several RCTs show consistent directional effects, though effect sizes are modest (typically 5-10 mmHg systolic). Spirulina is not a replacement for prescribed antihypertensive medications.
4. Antioxidant Activity and Reduction of Oxidative Stress
The antioxidant capacity of spirulina is among the most studied aspects of its pharmacology. This is not a general “antioxidant” marketing claim — the mechanisms are specific and well-characterized.
Phycocyanin, spirulina’s signature blue pigment, neutralizes reactive oxygen species (ROS) through direct radical scavenging, inhibition of lipid peroxidation, and upregulation of the body’s endogenous antioxidant defenses — including superoxide dismutase (SOD), catalase, and glutathione (Finamore et al., 2017).
Human studies measuring biomarkers of oxidative stress — including malondialdehyde (MDA) and 8-isoprostane — have shown significant reductions following spirulina supplementation. This reduction in systemic oxidative stress is likely the upstream driver of several of spirulina’s downstream clinical effects on lipids, blood sugar, and inflammation.
Evidence quality: High for biomarker outcomes. Less clinical data linking spirulina-induced antioxidant activity to specific disease outcomes in humans (much of the mechanistic data is in vitro or animal).
5. Reduction in Inflammatory Markers
Chronic low-grade inflammation underlies many of the most prevalent chronic diseases, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Spirulina addresses inflammation through several specific mechanisms.
C-phycocyanin acts as a selective inhibitor of cyclooxygenase-2 (COX-2) — the enzyme that produces prostaglandin E2, a mediator of inflammation and pain. It also reduces serum levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), two cytokines elevated in systemic inflammation (Karkos et al., 2011).
Human trials examining inflammatory markers after spirulina supplementation have shown significant reductions in hs-CRP (high-sensitivity C-reactive protein) in several populations, including those with metabolic syndrome and non-alcoholic fatty liver disease.
Evidence quality: Moderate. Mechanistic evidence is strong; clinical evidence for anti-inflammatory markers in humans is accumulating.
6. Allergic Rhinitis Symptom Relief
One of spirulina’s more surprising evidence-based applications is for seasonal allergies. A randomized, double-blind, placebo-controlled trial by Cingi et al. found that spirulina at 2 g/day for 12 weeks significantly reduced nasal symptoms in patients with allergic rhinitis, including discharge, sneezing, nasal congestion, and itching (Cingi et al., 2008).
The proposed mechanism involves phycocyanin’s inhibition of histamine release from mast cells — the same mast cells responsible for the allergic cascade triggered by pollen, pet dander, and other allergens.
Evidence quality: Moderate. Based on a well-designed RCT, though replication in additional trials would strengthen the evidence base.
7. Athletic Performance and Recovery
Spirulina has attracted interest in the athletic performance space, primarily for its antioxidant activity and its potential to reduce exercise-induced oxidative stress and muscle damage.
A 2010 randomized crossover study by Kalafati et al. found that spirulina supplementation at 6 g/day for 4 weeks improved time-to-fatigue during a running protocol and increased fat oxidation during exercise in trained athletes. Markers of oxidative stress post-exercise were also lower in the spirulina group (Kalafati et al., 2010).
A separate study found improvements in peak oxygen uptake (VO2 max) and exercise economy in sedentary individuals after spirulina supplementation, though effects in already-trained athletes tend to be smaller.
Spirulina’s protein content (60-70% by dry weight) also contributes a complete amino acid profile, supporting muscle protein synthesis when overall protein intake is adequate.
Evidence quality: Emerging. Promising results from several small trials. Effect sizes are modest and most studies are in recreationally active rather than elite-trained populations.
Notes on Evidence Quality
Not all spirulina benefits are supported equally. The lipid-lowering evidence is the strongest — multiple meta-analyses of RCTs, consistent direction, measurable effect sizes. The blood sugar, blood pressure, and antioxidant evidence is solid but based on fewer or shorter trials. Athletic performance and allergic rhinitis benefits are meaningful but rest on smaller evidence bases.
Most studies use doses between 3 and 8 grams per day. Benefits for lipid management and metabolic outcomes tend to require at least 4-6 weeks of consistent use. Spirulina is not a fast-acting intervention.
References
-
Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA. Antihyperlipemic and antihypertensive effects of spirulina maxima in an open sample of Mexican population. Lipids Health Dis. 2007;6:33. PMID: 17961209
-
Mazokopakis EE, Papadomanolaki MG, Fousteris AA, et al. The hepatoprotective and hypolipidemic effects of spirulina supplementation in a Cretan population with non-alcoholic fatty liver disease. Ann Gastroenterol. 2014;27(4):387-394. PMID: 24583915
-
Lee EH, Park JE, Choi YJ, Huh KB, Kim WY. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr Res Pract. 2008;2(4):295-300. PMID: 20016701
-
Miczke A, Szulinska M, Hansdorfer-Korzon R, et al. Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians. Eur Rev Med Pharmacol Sci. 2016;20(1):150-156. PMID: 26813468
-
Finamore A, Palmery M, Bensehaila S, Peluso I. Antioxidant, immunomodulating, and microbial-modulating activities of the sustainable and ecofriendly spirulina. Oxid Med Cell Longev. 2017;2017:3247528. PMID: 28254989
-
Deng R, Chow TJ. Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae spirulina. Cardiovasc Ther. 2010;28(4):e33-e45. PMID: 20105266
-
Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakopoulos DA. Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med. 2011;2011:531053. PMID: 21278375
-
Cingi C, Conk-Dalay M, Cakli H, Bal C. The effects of spirulina on allergic rhinitis. Eur Arch Otorhinolaryngol. 2008;265(10):1219-1223. PMID: 19030926
-
Kalafati M, Jamurtas AZ, Nikolaidis MG, et al. Ergogenic and antioxidant effects of spirulina supplementation in humans. Med Sci Sports Exerc. 2010;42(1):142-151. PMID: 20460905
This content is for informational purposes only and does not constitute medical advice.